Format: Download Video of Slides with Synchronized Audio

Presenter: Sharon McQuillan, MD

The obesity epidemic has reached pandemic proportions. Currently, two-thirds of all Americans are overweight or obese. Over the past 25 years, the number of obese individuals in the US has more than doubled. Globally, more than one billion adults are overweight with at least 300 million of them clinically obese. Obesity is a major contributor to the global burden of chronic disease and disability.

A novel surgical approach to surgical weight management involves debulking the subcutaneous tissue compartment with liposculpture. Liposuction is the second most popular elective surgical procedure according to the American Society for Aesthetic Plastic Surgery’s 2009 Cosmetic Statistics. Liposuction performed under tumescent local anesthesia enjoys a significant safety profile and high patient acceptance. Liposculpture offered in the context of hormone balancing, lifestyle guidance, and environmental toxin evaluation has been successful for continued weight loss in conjunction with an integrated program.

Learning Objectives:
-> Review metabolic sequelae of liposuction on obesity
-> Discuss role of liposuction in insulin resistance and inflammatory markers
-> Review improvements in lipid profile and cardiovascular risk profile